safety analysis
Showing 51 - 75 of >10,000
A Blind, Self Controlled, Multicenter Clinical Trial on
Recruiting
- CHD - Coronary Heart Disease
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Aug 9, 2021
Chronic Kidney Disease Trial in Brooklyn (Zibotentan (Treatment A), Dapagliflozin (Treatment A), Zibotentan/Dapagliflozin -
Completed
- Chronic Kidney Disease
- Zibotentan (Treatment A)
- +3 more
-
Brooklyn, MarylandResearch Site
Nov 22, 2021
Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)
Not yet recruiting
- Solid Tumor
- +5 more
- AZD1390
- Stereotactic Body Radiotherapy
-
New York, New York
- +1 more
Jan 12, 2023
Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- entolimod
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Effectiveness in Cystic Fibrosis
Active, not recruiting
- Cystic Fibrosis
- Contraception
-
Birmingham, Alabama
- +9 more
May 11, 2022
Postmenopausal Period, Vaginal Atrophy, Vaginal Prolapse Trial in Nizhny Novgorod (device, drug, diagnostic test, other)
Recruiting
- Postmenopausal Period
- +2 more
- Laser Treatment
- +14 more
-
Nizhny Novgorod, Russian FederationState-Funded Healthcare Institution of the Nizhny Novgorod regio
Nov 8, 2022
Chordoma Trial in Baltimore, New York (other, biological, radiation)
Active, not recruiting
- Chordoma
- Laboratory Biomarker Analysis
- +2 more
-
Baltimore, Maryland
- +1 more
Oct 3, 2022
Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in
Active, not recruiting
- Bone Marrow Transplantation Recipient
- +2 more
- Eltrombopag Olamine
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,
Active, not recruiting
- Partial Response of Multiple Myeloma or Plasma Cell Leukemia
- Plasma Cell Myeloma
- Incomplete Freund's Adjuvant
- +4 more
-
Buffalo, New York
- +1 more
Dec 12, 2022
Retrospective Follow-up of BIOLUX P-I/-II
Completed
- Overall Mortality
- Passeo-18
- Passeo-18 Lux
-
Graz, Austria
- +7 more
Aug 4, 2021
Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- +2 more
- Rivaroxaban (Xarelto, BAY59-7939)
- Apixaban
-
Wuppertal, GermanyBayer
Jul 25, 2022
Prostate Cancer, Focal Laser Ablation, Transperineal Laser Ablation Trial in Amsterdam (Echolaser X4 system)
Completed
- Prostate Cancer
- +2 more
- Echolaser X4 system
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Oct 15, 2021
Solid Tumor Trial in Duarte (RNR inhibitor COH29, laboratory biomarker analysis, pharmacological study)
Suspended
- Unspecified Adult Solid Tumor, Protocol Specific
- RNR inhibitor COH29
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Metastatic Malignant Tumor in the Brain, Metastatic Solid Tumor, Recurrent Colorectal Carcinoma Trial in Winston-Salem
Completed
- Metastatic Malignant Neoplasm in the Brain
- +11 more
- Laboratory Biomarker Analysis
- siRNA-transfected Peripheral Blood Mononuclear Cells APN401
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Durvalumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Analgesia in ÖAMTC Helicopter Emergency Service in Austria
Completed
- Field Physician Care
- +7 more
- analgesics
- hypnotics
-
Innsbruck, AustriaGeneral and Surgical Critical Care Medicine, Medical University
Sep 7, 2021
Latent Tuberculosis Infection Prophylaxis Treatment
Recruiting
- Adverse Reaction to Drug
- 3HP
-
Taipei, TaiwanInstitutional Review Board Chang Gung Medical Foundation
Dec 4, 2020
Lung Cancer, Lung Metastases Trial in United States (Nintedanib, Prednisone, Placebo)
Active, not recruiting
- Lung Cancer
- Lung Metastases
- Nintedanib
- +2 more
-
Boston, Massachusetts
- +11 more
Jul 19, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
EASINESS-TRIAL - Enhancing Safety in Epilepsy Surgery
Recruiting
- Epilepsy, Temporal Lobe
- Amygdalo-Hippocampal Epilepsy
- Mesial temporal lobe epilepsy surgery
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Jun 26, 2021
Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,
Recruiting
- Colorectal Cancer
- +3 more
- Glutaminase Inhibitor CB-839
- +5 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Mar 29, 2022
AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte
Active, not recruiting
- AIDS-related Non-Hodgkin Lymphoma
- +3 more
- busulfan
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +1 more
Jul 26, 2022
EchoNavigator System Release II During Structural Heart
Unknown status
- Cardiac Imaging Techniques
- Data analysis
-
Dusseldorf, GermanyDivision of Cardiology, Pulmonary Disease and Vascular Medicine
Feb 15, 2021